Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome-Reference-Cited by-同舟云学术

Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome

Published:2012-04-25 Issue:4 Volume:7 Page:e35986
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pecci Alessandro,Biino Ginevra,Fierro Tiziana,Bozzi Valeria,Mezzasoma Annamaria,Noris Patrizia,Ramenghi Ugo,Loffredo Giuseppe,Fabris Fabrizio,Momi Stefania,Magrini Umberto,Pirastu Mario,Savoia Anna,Balduini Carlo,Gresele Paolo,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

2. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.;A Pecci;Hum Mutat,2008

3. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.;MJ Kelley;Nat Genet,2000

4. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium.;M Seri;Nat Genet,2000

5. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin Anomaly and Fechtner, Sebastian, Epstein and Alport-like syndromes.;KE Heath;Am J Hum Genet,2001

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Muscle Myosin II A: Friend or Foe in Cancer?;International Journal of Molecular Sciences;2024-08-30

2. MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches;Research and Practice in Thrombosis and Haemostasis;2024-08

3. Measurement of immature platelet fraction is useful in the differential diagnosis of MYH9 disorders;International Journal of Laboratory Hematology;2023-06-16

4. Molecular determinants of peri‐apical targeting of inositol 1,4,5‐trisphosphate receptor type 3 in cholangiocytes;Hepatology Communications;2022-07-19

5. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure;Platelets;2022-07-05